Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rogers

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Plos One|March 9, 2023
China's changing expectations of the SCO between 2001 and 2019Xiaohan Xu, Roy Anthony Rogers
Computational Economics|September 26, 2022
A Novel Prediction Model: ELM-ABC for Annual GDP in the Case of SCO CountriesXiaohan Xu, Roy Anthony Rogers, Mario Arturo Ruiz Estrada
Plos One|August 24, 2019
More landings for higher profit? Inverse demand analysis of the bluefin tuna auction price in Japan and economic incentives in global bluefin tuna fisheries managementChin-Hwa Sun, Fu-Sung Chiang, Dale Squires, et al.
Plos Genetics|May 16, 2013
Duplication and retention biases of essential and non-essential genes revealed by systematic knockdown analysesShane Woods, Avril Coghlan, David Rivers, et al.
BMJ Open|August 20, 2018
Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative studyAbdul Salam, Ruth Webster, Anushka Patel, et al.
Marine Policy|April 15, 2020
Changing the narrative on fisheries subsidies reform: Enabling transitions to achieve SDG 14.6 and beyondAndrés M Cisneros-Montemayor, Yoshitaka Ota, Megan Bailey, et al.
Frontline Gastroenterology|March 19, 2013
Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissionsNeill R Hughes, Natalie Houghton, Haitham Nadeem, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
BMC Medical Genomics|January 6, 2026
Defining an approach to empower clinical geneticists to do genomic reanalysisMichael M Segal, Meriel McEntagart, Alexander T Deng, et al.
Diabetes Care|May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE TrialTu N Nguyen, Katie Harris, Mark Woodward, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Plos One|March 9, 2023
China's changing expectations of the SCO between 2001 and 2019Xiaohan Xu, Roy Anthony Rogers
Computational Economics|September 26, 2022
A Novel Prediction Model: ELM-ABC for Annual GDP in the Case of SCO CountriesXiaohan Xu, Roy Anthony Rogers, Mario Arturo Ruiz Estrada
Plos One|August 24, 2019
More landings for higher profit? Inverse demand analysis of the bluefin tuna auction price in Japan and economic incentives in global bluefin tuna fisheries managementChin-Hwa Sun, Fu-Sung Chiang, Dale Squires, et al.
Plos Genetics|May 16, 2013
Duplication and retention biases of essential and non-essential genes revealed by systematic knockdown analysesShane Woods, Avril Coghlan, David Rivers, et al.
BMJ Open|August 20, 2018
Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative studyAbdul Salam, Ruth Webster, Anushka Patel, et al.
Marine Policy|April 15, 2020
Changing the narrative on fisheries subsidies reform: Enabling transitions to achieve SDG 14.6 and beyondAndrés M Cisneros-Montemayor, Yoshitaka Ota, Megan Bailey, et al.
Frontline Gastroenterology|March 19, 2013
Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissionsNeill R Hughes, Natalie Houghton, Haitham Nadeem, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
BMC Medical Genomics|January 6, 2026
Defining an approach to empower clinical geneticists to do genomic reanalysisMichael M Segal, Meriel McEntagart, Alexander T Deng, et al.
Diabetes Care|May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE TrialTu N Nguyen, Katie Harris, Mark Woodward, et al.
Pageof 2